24 June 2024

Amedeo Smart

Independent Medical Education

Subscriber: th..@boehringer-ingelheim.com

HIV Infection

24 June 2024 | n=26

  1. Martinson T, Montoya R, Moreira C, Kuncze K, et al.
    Point-of-care urine tenofovir test predicts future HIV pre-exposure prophylaxis discontinuation among young users.
    AIDS 2024.

  2. King JM, Dobbins T, Keen P, Cornelisse VJ, et al.
    Trends in HIV testing and HIV stage at diagnosis among people newly diagnosed with HIV.
    AIDS 2024.

  3. Yotebieng M, Zotova N, Bernard C, Goodrich S, et al.
    Accuracy of PHQ-9 against psychiatric diagnosis for depression among people living with HIV: A multicounty cross-sectional study.
    AIDS 2024.

  4. Michael HU, Brouillette MJ, Tamblyn R, Fellows LK, et al.
    Cognitive impact of anticholinergic and sedative burden in people living with HIV.
    AIDS 2024.

  5. Rose PC, Davies C, Cotton MF, Otwombe K, et al.
    Longitudinal controlled attenuation parameter and liver stiffness in children with and without perinatal HIV infection in South Africa.
    AIDS 2024.

  6. Schnittman SR, Talathi R, Wilks MQ, Hedgire S, et al.
    Association of T-cell subtypes with macrophage-specific arterial infiltration in PWH.
    AIDS 2024.

  7. Russo SC, Ockene MW, Arpante AK, Johnson JE, et al.
    Efficacy and safety of tesamorelin in people with hiv on integrase inhibitors.
    AIDS 2024.

  8. Blair J, Kempf MC, Dionne JA, Causey-Pruitt Z, et al.
    Awareness, treatment, and control of hypertension among women at risk or living with HIV in the US South: a prospective study.
    AIDS 2024.

  9. Inceer M, Boehnke J, Brouillette MJ, Fellows LK, et al.
    In Support of Multidimensional Frailty: A Structural Equation Model from the Canadian Positive Brain Health Now Cohort.
    AIDS Res Hum Retroviruses 2024.

  10. McCrimmon T, Collins LF, Pereyra M, Platamone C, et al.
    Likelihood of Trying Long-Acting Injectable Antiretroviral Therapy Among Women With HIV in Nine Sites Across the United States.
    J Acquir Immune Defic Syndr 2024;96:e23-e27.

  11. Oyuga R, Amadi E, Blanco N, Ndaga A, et al.
    Effects of Multimonth Dispensing on Viral Suppression and Continuity in Treatment Among Children Living With HIV Aged 2-9 Years: A Cohort Study in Western Kenya.
    J Acquir Immune Defic Syndr 2024;96:290-298.

  12. Calabrese SK, Zaheer MA, Flores JJ, Kalwicz DA, et al.
    Messaging About HIV Transmission Risk When Viral Load Is Undetectable: Reactions and Perceived Accuracy Among US Sexual Minority Men.
    J Acquir Immune Defic Syndr 2024;96:270-279.

  13. Audet CM, Graves E, Shepherd BE, Prigmore HL, et al.
    Partner-Based HIV Treatment for Seroconcordant Couples Attending Antenatal and Postnatal Care in Rural Mozambique: A Cluster Randomized Controlled Trial.
    J Acquir Immune Defic Syndr 2024;96:259-269.

  14. Vitruk O, Ihnatiuk AP, Kazanzhy AP, Shvab M, et al.
    Uptake and Persistent Use of HIV Preexposure Prophylaxis Among Key Populations: Results From Ukraine's Scaled National Preexposure Prophylaxis Program.
    J Acquir Immune Defic Syndr 2024;96:241-249.

  15. Bakoyannis G, Elul B, Wools-Kaloustian KK, Brown S, et al.
    Modeling the HIV Cascade of Care Using Routinely Collected Clinical Data to Guide Programmatic Interventions and Policy Decisions.
    J Acquir Immune Defic Syndr 2024;96:223-230.

  16. Peters BA, Hanna DB, Xue X, Weber K, et al.
    Menopause and Estrogen Associations With Gut Barrier, Microbial Translocation, and Immune Activation Biomarkers in Women With and Without HIV.
    J Acquir Immune Defic Syndr 2024;96:214-222.

  17. Choi J, May SB, Dang BN, Markham C, et al.
    Acceptability of a Future HIV Vaccine: A Rapid Scoping Review.
    J Acquir Immune Defic Syndr 2024;96:197-207.

  18. Dirajlal-Fargo S, Sattar A, Strah M, Karungi C, et al.
    Immune activation is associated with neurocognitive performance in Ugandan Adolescents living with HIV.
    J Acquir Immune Defic Syndr 2024.

  19. Golloshi K, Mitchell W, Kumar D, Malik S, et al.
    HLH and Recurrent EBV Lymphoma as the presenting manifestation of MAGT1 Deficiency: A Systematic Review of the Expanding Disease Spectrum.
    J Clin Immunol 2024;44:153.

  20. Wang F, Rademeyer K, Namuju OC, Abdusalaamu K, et al.
    Post-mortem analysis of dolutegravir, tenofovir, lamivudine and efavirenz penetration in multiple CNS compartments.
    J Infect Dis 2024.

  21. Chow EPF, Stevens K, De Petra V, Chen MY, et al.
    Prevalence of cefixime-resistant Neisseria gonorrhoeae in Melbourne, Australia, 2021-2022.
    J Infect Dis 2024.

  22. Jacobson DL, Crider KS, DeMarrais P, Brummel S, et al.
    Dolutegravir- Versus Efavirenz-Based Treatment in Pregnancy: Impact on Red Blood Cell Folate Concentrations in Pregnant Women and Their Infants.
    J Infect Dis 2024.

  23. Chen R, Fu Y, Li D, Wang S, et al.
    Proteomic analysis of plasma in healthy adults receiving recombinant vaccinia virus provides novel insights into HIV-1 neutralizing antibodies.
    J Med Virol 2024;96:e29749.

  24. Mooko T, Bisiwe FB, Chikobvu P, Morobadi MD, et al.
    The prevalence of HIV resistance mutations and their influence on the shedding of HIV-1 into peritoneal dialysis effluent.
    J Med Virol 2024;96:e29734.

  25. Roesmann F, Sertznig H, Klaassen K, Wilhelm A, et al.
    The interferon-regulated host factor hnRNPA0 modulates HIV-1 production by interference with LTR activity, mRNA trafficking, and programmed ribosomal frameshifting.
    J Virol 2024.

  26. Adepoju P.
    Meet the PrEP ambassadors who use social media to combat HIV.
    Nat Med 2024;30:1510-1512.

Display articles in

Amedeo HIV Infection

Data Origin

You selected the following journals for your Amedeo HIV Infection newsletter:

AIDS, AIDS Res Hum Retroviruses, Ann Intern Med, BMJ, Clin Infect Dis, J Acquir Immune Defic Syndr, J Clin Immunol, J Clin Invest, J Infect Dis, J Med Virol, J Virol, JAMA, Lancet, N Engl J Med, Nat Med, Pediatr Infect Dis J, Science, Virology.

To modify the journal selection, please open your Newsletter Management Page. If you don't remember the URL, please submit the email address of your Amedeo subscription.

Your email:

Amedeo HIV Infection

Five-Week Literature

15 July 2024

08 July 2024

01 July 2024

24 June 2024

17 June 2024

24 June 2024

Multidisciplinary Journal Club

  1. Simon GE, Moise N, Mohr DC.
    Management of Depression in Adults: A Review.
    JAMA. 2024 Jun 10. doi: 10.1001/jama.2024.5756.

  2. Kelly P, Lemmens R, Weimar C, Walsh C, et al.
    Long-term colchicine for the prevention of vascular recurrent events in non-cardioembolic stroke (CONVINCE): a randomised controlled trial.
    Lancet. 2024 Jun 7:S0140-6736(24)00968-1. doi: 10.1016/S0140-6736(24)00968.

  3. Li M, Bhoori S, Mehta N, Mazzaferro V, et al.
    Immunotherapy for hepatocellular carcinoma: the next evolution in expanding access to liver transplantation.
    J Hepatol. 2024 Jun 5:S0168-8278(24)00423-9. doi: 10.1016/j.jhep.2024.

Every week, Amedeo's Multidisciplinary Journal Club (MJC) presents a selection of outstanding articles. Take a look beyond the horizon.

Privacy Policy